Fisher & Paykel Healthcare Corporation Limited (FPH.AX)
AUD 32.64
(0.02%)
AUD 32.64
(0.02%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | 132.6 Million NZD | -47.02% |
| 2023 | 250.3 Million NZD | -33.59% |
| 2022 | 376.9 Million NZD | -28.1% |
| 2021 | 524.2 Million NZD | 82.46% |
| 2020 | 287.3 Million NZD | 37.33% |
| 2019 | 209.2 Million NZD | 9.99% |
| 2018 | 190.2 Million NZD | 12.44% |
| 2017 | 169.15 Million NZD | 17.94% |
| 2016 | 143.42 Million NZD | 26.73% |
| 2015 | 113.17 Million NZD | 16.61% |
| 2014 | 97.05 Million NZD | 25.96% |
| 2013 | 77.05 Million NZD | 20.19% |
| 2012 | 64.11 Million NZD | 22.19% |
| 2011 | 52.46 Million NZD | -26.76% |
| 2010 | 71.63 Million NZD | 15.1% |
| 2009 | 62.23 Million NZD | 76.42% |
| 2008 | 35.27 Million NZD | -38.76% |
| 2007 | 57.6 Million NZD | -17.67% |
| 2006 | 69.96 Million NZD | 13.94% |
| 2005 | 61.4 Million NZD | 12.26% |
| 2004 | 54.69 Million NZD | -24.97% |
| 2003 | 72.9 Million NZD | 51.48% |
| 2002 | 48.12 Million NZD | 395.81% |
| 2001 | 9.7 Million NZD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q4 | 25.3 Million NZD | 0.0% |
| 2024 FY | 132.6 Million NZD | -47.02% |
| 2024 Q2 | 107.3 Million NZD | 0.0% |
| 2023 FY | 250.3 Million NZD | -33.59% |
| 2023 Q4 | 154.4 Million NZD | 0.0% |
| 2023 Q2 | 95.9 Million NZD | 0.0% |
| 2022 Q4 | 155.1 Million NZD | 0.0% |
| 2022 Q2 | 221.8 Million NZD | 0.0% |
| 2022 FY | 376.9 Million NZD | -28.1% |
| 2021 FY | 524.2 Million NZD | 82.46% |
| 2021 Q4 | 298.7 Million NZD | 0.0% |
| 2021 Q2 | 225.5 Million NZD | 0.0% |
| 2020 Q4 | 166.1 Million NZD | 0.0% |
| 2020 Q2 | 121.2 Million NZD | 0.0% |
| 2020 FY | 287.3 Million NZD | 37.33% |
| 2019 Q4 | 111.8 Million NZD | 0.0% |
| 2019 FY | 209.2 Million NZD | 9.99% |
| 2019 Q2 | 97.4 Million NZD | 0.0% |
| 2018 Q4 | 108.9 Million NZD | 0.0% |
| 2018 FY | 190.2 Million NZD | 12.44% |
| 2018 Q2 | 81.3 Million NZD | 0.0% |
| 2017 Q4 | 91 Million NZD | 0.0% |
| 2017 FY | 169.15 Million NZD | 17.94% |
| 2017 Q2 | 78.2 Million NZD | 0.0% |
| 2016 Q2 | 62.03 Million NZD | 0.0% |
| 2016 FY | 143.42 Million NZD | 26.73% |
| 2016 Q4 | 81.38 Million NZD | 0.0% |
| 2015 FY | 113.17 Million NZD | 16.61% |
| 2015 Q4 | 64.25 Million NZD | 0.0% |
| 2015 Q2 | 48.91 Million NZD | 0.0% |
| 2014 Q3 | 24.26 Million NZD | -45.47% |
| 2014 Q4 | 52.56 Million NZD | 116.63% |
| 2014 Q1 | 19.26 Million NZD | -56.02% |
| 2014 FY | 97.05 Million NZD | 25.96% |
| 2014 Q2 | 44.49 Million NZD | 130.97% |
| 2013 Q1 | 16.02 Million NZD | 0.0% |
| 2013 Q2 | 16.02 Million NZD | 0.0% |
| 2013 Q3 | 19.26 Million NZD | 20.19% |
| 2013 FY | 77.05 Million NZD | 20.19% |
| 2013 Q4 | 43.8 Million NZD | 127.38% |
| 2012 Q4 | 16.02 Million NZD | 0.0% |
| 2012 FY | 64.11 Million NZD | 22.19% |
| 2012 Q3 | 16.02 Million NZD | 22.19% |
| 2012 Q2 | 13.11 Million NZD | 0.0% |
| 2012 Q1 | 13.11 Million NZD | 0.0% |
| 2011 Q4 | 13.11 Million NZD | 0.0% |
| 2011 Q1 | 17.9 Million NZD | 0.0% |
| 2011 Q3 | 13.11 Million NZD | -26.76% |
| 2011 FY | 52.46 Million NZD | -26.76% |
| 2011 Q2 | 17.9 Million NZD | 0.0% |
| 2010 Q4 | 17.9 Million NZD | 0.0% |
| 2010 FY | 71.63 Million NZD | 15.1% |
| 2010 Q1 | 15.55 Million NZD | 0.0% |
| 2010 Q2 | 15.55 Million NZD | 0.0% |
| 2010 Q3 | 17.9 Million NZD | 15.1% |
| 2009 FY | 62.23 Million NZD | 76.42% |
| 2009 Q4 | 15.55 Million NZD | 0.0% |
| 2009 Q2 | 8.81 Million NZD | 0.0% |
| 2009 Q1 | 8.81 Million NZD | 0.0% |
| 2009 Q3 | 15.55 Million NZD | 76.42% |
| 2008 Q2 | 14.4 Million NZD | 0.0% |
| 2008 Q4 | 8.81 Million NZD | 0.0% |
| 2008 Q1 | 14.4 Million NZD | 0.0% |
| 2008 FY | 35.27 Million NZD | -38.76% |
| 2008 Q3 | 8.81 Million NZD | -38.76% |
| 2007 Q4 | 14.4 Million NZD | 0.0% |
| 2007 Q1 | 17.49 Million NZD | 0.0% |
| 2007 Q2 | 17.49 Million NZD | 0.0% |
| 2007 Q3 | 14.4 Million NZD | -17.67% |
| 2007 FY | 57.6 Million NZD | -17.67% |
| 2006 Q1 | 15.35 Million NZD | 0.0% |
| 2006 Q4 | 17.49 Million NZD | 0.0% |
| 2006 FY | 69.96 Million NZD | 13.94% |
| 2006 Q3 | 17.49 Million NZD | 13.94% |
| 2006 Q2 | 15.35 Million NZD | 0.0% |
| 2005 Q3 | 15.35 Million NZD | 12.26% |
| 2005 Q2 | 13.67 Million NZD | 0.0% |
| 2005 Q1 | 13.67 Million NZD | 0.0% |
| 2005 Q4 | 15.35 Million NZD | 0.0% |
| 2005 FY | 61.4 Million NZD | 12.26% |
| 2004 Q1 | 18.22 Million NZD | 0.0% |
| 2004 Q2 | 18.22 Million NZD | 0.0% |
| 2004 Q3 | 13.67 Million NZD | -24.97% |
| 2004 Q4 | 13.67 Million NZD | 0.0% |
| 2004 FY | 54.69 Million NZD | -24.97% |
| 2003 Q1 | 12.03 Million NZD | 0.0% |
| 2003 Q3 | 18.22 Million NZD | 51.48% |
| 2003 FY | 72.9 Million NZD | 51.48% |
| 2003 Q4 | 18.22 Million NZD | 0.0% |
| 2003 Q2 | 12.03 Million NZD | 0.0% |
| 2002 Q1 | 2.42 Million NZD | 0.0% |
| 2002 FY | 48.12 Million NZD | 395.81% |
| 2002 Q4 | 12.03 Million NZD | 0.0% |
| 2002 Q3 | 12.03 Million NZD | 395.81% |
| 2002 Q2 | 2.42 Million NZD | 0.0% |
| 2001 Q3 | 2.42 Million NZD | 0.0% |
| 2001 FY | 9.7 Million NZD | 0.0% |
| 2001 Q4 | 2.42 Million NZD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Austco Healthcare Limited | 7.07 Million AUD | -1773.94% |
| Nanosonics Limited | 12.97 Million AUD | -922.202% |
| Osteopore Limited | -4.87 Million AUD | 2821.685% |
| SDI Limited | 10.42 Million AUD | -1172.431% |
| Trajan Group Holdings Limited | -25.32 Million AUD | 623.511% |